Clinical Trial Update: Effect of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability and Oxidative Stress [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update examines the effect of a DPP-4 inhibitor combined with a sulfonylurea on glucose variability and oxidative stress in Type 2 d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dipeptidyl Peptidase-IV inhibitor
• Sulfonylurea (sulfonylurea)

Snippet

Sponsor: The Catholic University of Korea | Conditions: Type 2 Diabetes | Phase 4 | Status: UNKNOWN